Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial*
British Journal of Dermatology2020Vol. 184(5), pp. 828–839
Citations Over TimeTop 10% of 2020 papers
Kim S Thomas, Jonathan Batchelor, Perways Akram, Joanne R Chalmers, Rachel Haines, Garry Meakin, Lelia Duley, Jane Ravenscroft, Andy Rogers, Tracey Sach, Miriam Santer, Wei Tan, Jennifer White, Maxine E Whitton, Hywel C Williams, Seau Tak Cheung, Hamdi Hamad, Andrew Wright, John R Ingram, N. J. Levell, J. M. R. Goulding, Areti Makrygeorgou, Anthony Bewley, Malobi Ogboli, J. Stainforth, Adam Ferguson, Bisola Laguda, Shyamal Wahie, Robert Ellis, J. Azad, Amirtha Rajasekaran, Viktoria Eleftheriadou, Alan Montgomery
Abstract
Combination treatment with home-based handheld NB-UVB plus TCS is likely to be superior to TCS alone for treatment of localized vitiligo. Combination treatment was relatively safe and well tolerated but was successful in only around one-quarter of participants.
Related Papers
- → Hyperpigmentation in photo exposed patches of vitiligo following tacrolimus therapy(2014)9 cited
- → Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream(2007)24 cited
- Vitiligo Lesions Improved after Oral Cyclosporine in a Patient with Vitiligo and Atopic Dermatitis(2012)
- Treatment of vitiligo with topical PUVA(2001)
- A Case of Vitiligo Repigmented with Topical Tacrolimus(2004)